Jay Venkatesan - Dec 16, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
President and Chief Executive Officer and Director, Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Stock symbol
ELTX
Transactions as of
Dec 16, 2021
Transactions value $
$105,951
Form type
4
Date filed
12/20/2021, 05:44 PM
Previous filing
Sep 21, 2021
Next filing
Dec 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Purchase $71K +27.9K +2.12% $2.55 1.34M Dec 16, 2021 Direct F1
transaction ELTX Common Stock Purchase $35K +13.7K +1.02% $2.54 1.36M Dec 17, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.55 inclusive.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.55 inclusive.

Remarks:

President and Chief Executive Officer and Director